A detailed history of Dmg Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Dmg Group, LLC holds 6,952 shares of BSX stock, worth $604,754. This represents 0.48% of its overall portfolio holdings.

Number of Shares
6,952
Previous 5,918 17.47%
Holding current value
$604,754
Previous $455,000 27.91%
% of portfolio
0.48%
Previous 0.39%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$72.96 - $84.0 $75,440 - $86,856
1,034 Added 17.47%
6,952 $582,000
Q2 2024

Jul 16, 2024

BUY
$67.33 - $77.71 $46,525 - $53,697
691 Added 13.22%
5,918 $455,000
Q1 2024

Apr 19, 2024

BUY
$57.6 - $68.62 $17,971 - $21,409
312 Added 6.35%
5,227 $357,000
Q4 2023

Jan 10, 2024

BUY
$48.64 - $57.81 $42,219 - $50,179
868 Added 21.45%
4,915 $284,000
Q3 2023

Oct 26, 2023

BUY
$50.19 - $54.68 $203,118 - $221,289
4,047 New
4,047 $213,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Dmg Group, LLC Portfolio

Follow Dmg Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.